A promiscuous interaction of SARS-CoV-2 with bacterial products.

Carissimo, Guillaume; Ng, Lisa F P

Carissimo, Guillaume; Ng, Lisa F P.

Carissimo G; A*STAR Infectious Disease laboratories (A*ID Labs), Agency for Science, Technology and Research, Immunos, Singapore 138648, Singapore.
Ng LFP; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research, Immunos, Singapore 138648, Singapore.

J Mol Cell Biol ; 12(12): 914-915, 2020 11 18.

Article in English | MEDLINE | ID: covidwho-1387924

Subject(s)

COVID-19/complications; SARS-CoV-2; COVID-19/immunology; Cytokine Release Syndrome/etiology; Cytokine Release Syndrome/immunology; Gram-Negative Bacterial Infections/complications; Gram-Negative Bacterial Infections/immunology; Humans; Lipopolysaccharides/chemistry; Lipopolysaccharides/immunology; Models, Immunological; Risk Factors; SARS-CoV-2/immunology; Spike Glycoprotein, Coronavirus/chemistry; Spike Glycoprotein, Coronavirus/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Mol Cell Biol Journal subject: Molecular Biology Year: 2020 Document Type: Article Affiliation country: JMCB

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google